JD Health International Inc. (HKG:6618)
Hong Kong
· Delayed Price · Currency is HKD 34.00
-1.65 (-4.63%)
Mar 12, 2025, 4:08 PM HKT
JD Health International Revenue
In the year 2024, JD Health International had annual revenue of 58.16B CNY with 8.65% growth. JD Health International had revenue of 29.82B in the half year ending December 31, 2024, with 12.47% growth.
Revenue
58.16B CNY
Revenue Growth
+8.65%
P/S Ratio
1.73
Revenue / Employee
16.32M CNY
Employees
3,564
Market Cap
108.75B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.00B |
| WuXi Biologics | 18.39B |
| Alibaba Health Information Technology | 31.39B |
| Innovent Biologics | 8.01B |
| Sino Biopharmaceutical | 29.86B |
| Akeso | 2.01B |
| Sinopharm Group | 634.32B |